Mechanics
Negotiation
Most people leave significant money on the table because they don't understand the comp structure they're negotiating, don't have competing options, or don't ask. In deep tech, the three compensation structures — startup equity, VC carry, and corporate RSUs/bonus — are different enough that the same negotiation tactics don't apply to all three.
| Dimension | Startup Equity | VC Carry | Corporate RSU/Bonus |
|---|---|---|---|
| Key variable | % fully diluted + liquidation prefs | % carry + fund size + DPI | Grade level + RSU refresh cadence |
| Risk profile | High — most companies don't exit | Long-dated — 7–10 yr fund cycle | Low — deferred comp, not upside bet |
| Negotiation lever | % equity, vesting, cliff terms | Carry %, co-invest rights | Entry grade, initial RSU grant, bonus floor |
| When value is realized | Liquidity event (acq or IPO) | Fund wind-down + distributions | 4-yr vest + annual cycle |
| MBA multiplier | Medium — execution beats signaling | High — MBA + deal flow thesis matters | High — negotiate a higher grade entry |
The first rule
Never negotiate from a single offer if you can avoid it. Everything else in this page is secondary to that. Run parallel processes with deliberate timing so you arrive at decision point with multiple options. Options give you leverage that no negotiation tactic can manufacture.
Startup Equity
Operator roles at private companies
Base salary
Typically below market vs. equivalent corporate role — the equity is supposed to compensate. Make sure the equity story actually holds up before accepting this trade.
Equity grant (options or RSUs)
The critical number is % of fully diluted shares, not absolute share count. Demand this number. 0.25% of a $100M company with clean cap table > 2% of a $5M company with heavy liquidation preferences.
Vesting schedule
Standard: 4 years, 1-year cliff (25% vests after year 1, then monthly). Anything more aggressive (longer cliff, back-weighted) is a red flag.
Exercise price (for options)
The strike price for options is set at 409A valuation. In a rapidly appreciating company, this becomes significant. Ask when the last 409A was done.
Questions to ask
- ›“What is the fully diluted share count, and what percentage does this grant represent?”
- ›“What is the last 409A valuation, and when was it done?”
- ›“What is the liquidation preference structure? Is preferred 1x non-participating?”
- ›“What is the current runway, and when do you anticipate the next raise?”
- ›“What is the realistic exit timeline the founders and board are targeting?”
VC / Fund Compensation
Investor roles at VC funds
Base salary
Associate/Principal: $120K–$250K depending on fund size and geography. Israeli funds trend below US funds at comparable levels. Negotiable at senior levels.
Carry (carried interest)
Your % of the fund's profits above the hurdle rate (typically 8%). Associates typically get 0.25–1% of the fund. On a $200M fund returning 3x net: ~$1.5M carry pool; 0.5% carry = ~$7.5K–$15K per deal, paid out over 7–10 years. Not life-changing at junior levels.
Co-investment rights
The ability to personally invest in fund deals at the same terms as the fund. This is often worth more than carry for people who have capital to deploy.
Questions to ask
- ›“What is the total carry pool as a percentage of AUM, and what percentage would my role receive?”
- ›“What is the fund's carried interest distribution waterfall?”
- ›“Are there co-investment rights associated with this role, and what are the terms?”
- ›“What does the path from Associate to Partner look like at this fund, and what's the typical timeline?”
Corporate / Enterprise Compensation
Roles at Intel, Google, Microsoft, IAI, Elbit, etc.
Base salary
Set by grade/band. The MBA should get you a higher starting grade — negotiate grade level, not just salary, because grade affects future annual increases.
Annual bonus
Target 10–20% of base. Ask what the actual payout has been for the last 3 years and what triggers max payout vs. zero payout.
RSUs
Restricted Stock Units in publicly traded company stock. Vesting over 4 years. This is deferred compensation, not equity upside. Negotiate the initial grant and ask about annual refresh grants.
Benefits package
In Israel: pension (קרן פנסיה) contributions are legally required (employer matches 6.5%+). Continuing education budget, study fund (קרן השתלמות) — these are real money. Negotiate them.
Questions to ask
- ›“What grade level is this role, and is there flexibility to enter at a higher grade given my MBA and experience?”
- ›“What has been the actual bonus payout for this role level in the last three years?”
- ›“What is the typical RSU refresh grant for strong performers, and when are they reviewed?”
- ›“Is there a study fund (קרן השתלמות) included in the package?”
Israeli Equity Mechanics
Negotiating equity with an Israeli company requires understanding structures that don't appear in standard US compensation guides. These are the points where people most commonly leave money on the table or get surprised post-signing.
Section 102 — Capital Gains vs. Ordinary Income Track
Israeli companies grant options under Section 102 of the Israeli Tax Ordinance. Capital gains track (102 Capital): options held in a trustee arrangement for a minimum of 24 months are taxed at ~25% capital gains rates — significantly better than marginal income tax rates (up to 47–50%). Most candidates assume their grant is on this track; verify it explicitly. Some early-stage companies default to the Ordinary income track because they haven't established a trustee arrangement.
Questions to ask
- ›“Are my options granted under Section 102 Capital Gains track?”
- ›“Who is the appointed trustee, and when does the 24-month holding period begin for my grant?”
- ›“If I leave before 24 months, what happens to the tax treatment of vested options?”
Phantom Shares vs. Real Options
Some Israeli companies — particularly pre-seed and early seed — issue phantom shares (also called virtual shares or synthetic equity) rather than actual options. Real options give you the legal right to purchase actual shares, convey ownership, and have legal protections in acquisition scenarios. Phantom shares are contractual rights to a cash payment calculated as if you held real shares — no actual ownership, and their treatment in an acquisition is at the company's discretion.
Questions to ask
- ›“Am I receiving actual stock options or phantom/synthetic equity?”
- ›“If phantom, what are the acquisition treatment terms, and are they defined in writing before I sign?”
The Fully Diluted Percentage
Israeli startup offer letters typically state a number of options (e.g., '10,000 options at ₪0.01 strike price'). Without the total fully diluted share count, this number tells you nothing. A 10,000-option grant in a company with 1,000,000 diluted shares (1.0%) is a fundamentally different offer from the same grant in a company with 20,000,000 diluted shares (0.05%). The offer letter will not tell you which situation you're in unless you ask. Reputable companies will share this; if a company declines, that is a data point.
Questions to ask
- ›“What are total shares outstanding, fully diluted (including all authorized option pools)?”
- ›“What percentage of fully diluted does my grant represent?”
Fair Market Value Timing
Israeli companies set option strike prices based on a board-approved FMV determination (functionally similar to a 409A in the US). If the company is actively closing a funding round, the FMV will increase at close. Options granted before a round close carry a lower strike price relative to the new valuation — this has real economic value.
Questions to ask
- ›“When was your last FMV determination?”
- ›“Is there an active fundraising process or anticipated FMV event in the next 90 days?”
The Options Agreement — A Separate Document
The offer letter states the number of options. The actual terms — tax track, vesting schedule, acceleration provisions, post-termination exercise window, and transfer restrictions — are in a separate Options Agreement and the company's Equity Incentive Plan. Do not sign an offer letter with equity as a meaningful component before reviewing both documents. Post-termination exercise window: standard is 90 days after leaving. Some companies offer 12 months or longer — this is negotiable and has real value in early-stage companies where an exit may be years away.
Questions to ask
- ›“Can I review the Options Agreement and Equity Incentive Plan before signing the offer?”
- ›“What is the post-termination exercise window for vested options?”
The Actual Negotiation Conversation
Don't anchor first
If they ask for your salary expectation, redirect: 'I'd like to understand the full comp picture first before naming a number — can you share the range for this role?' They usually will.
Anchor high when you must
If pressed for a number, anchor at the top of your researched range, not the middle. You can negotiate down. You can't negotiate up.
Negotiate the package, not just base
Base salary is the most visible component but often the most constrained by grade bands. Signing bonus, RSU grant size, title, start date, remote flexibility — all negotiable, often more than base.
Use competing offers correctly
'I have another offer at X' is powerful but must be true. Don't fabricate. You can be truthful about a strong interest from another organization without misrepresenting a hard offer.
Get it in writing before you resign
Verbal offers are not offers. Do not give notice at your current employer until you have a signed offer letter. In Israeli employment, the offer letter and the options agreement are separate documents. Both matter. A signed offer letter that references a pending options agreement is not a complete equity commitment — make sure the options agreement is also reviewed and signed before you give notice, if equity is a material part of the compensation.
Use the Comp Decoder to model startup equity, VC carry, and corporate RSU scenarios side by side.
Open Comp Decoder →